MAUNA KEA TECHNOLOGIES (ALMKT.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:ALMKT - FR0010609263 - Common Stock
0.0808 EUR
+0 (+1.51%)
We assign a fundamental rating of 2 out of 10 to ALMKT. ALMKT was compared to 68 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of ALMKT have multiple concerns. ALMKT has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year ALMKT has reported negative net income.
In the past year ALMKT has reported a negative cash flow from operations.
ALMKT had negative earnings in each of the past 5 years.
In the past 5 years ALMKT always reported negative operating cash flow.
1.2 Ratios
The Return On Assets of ALMKT (-82.18%) is worse than 89.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -82.18% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-45.6%
ROA(5y)-50.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 31.67%, ALMKT is not doing good in the industry: 80.88% of the companies in the same industry are doing better.
ALMKT's Gross Margin has improved in the last couple of years.
ALMKT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 31.67% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y39.93%
GM growth 5YN/A
2. Health
2.1 Basic Checks
ALMKT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALMKT has more shares outstanding
The number of shares outstanding for ALMKT has been increased compared to 5 years ago.
The debt/assets ratio for ALMKT is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of -7.85, we must say that ALMKT is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -7.85, ALMKT is doing worse than 85.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -7.85 |
ROIC/WACCN/A
WACC6.69%
2.3 Liquidity
ALMKT has a Current Ratio of 0.23. This is a bad value and indicates that ALMKT is not financially healthy enough and could expect problems in meeting its short term obligations.
ALMKT has a worse Current ratio (0.23) than 91.18% of its industry peers.
ALMKT has a Quick Ratio of 0.23. This is a bad value and indicates that ALMKT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.12, ALMKT is doing worse than 94.12% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.23 | ||
| Quick Ratio | 0.12 |
3. Growth
3.1 Past
The earnings per share for ALMKT have decreased strongly by -114.81% in the last year.
Looking at the last year, ALMKT shows a very negative growth in Revenue. The Revenue has decreased by -26.96% in the last year.
The Revenue has been growing slightly by 0.60% on average over the past years.
EPS 1Y (TTM)-114.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.27%
Revenue 1Y (TTM)-26.96%
Revenue growth 3Y-0.2%
Revenue growth 5Y0.6%
Sales Q2Q%-4.62%
3.2 Future
ALMKT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.86% yearly.
The Revenue is expected to grow by 26.82% on average over the next years. This is a very strong growth
EPS Next Y50%
EPS Next 2Y74.64%
EPS Next 3Y23.86%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y38.6%
Revenue Next 3Y26.82%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ALMKT. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 0.75, the valuation of ALMKT can be described as very cheap.
Based on the Price/Forward Earnings ratio, ALMKT is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
ALMKT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.04.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 0.75 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
ALMKT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALMKT's earnings are expected to grow with 23.86% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y74.64%
EPS Next 3Y23.86%
5. Dividend
5.1 Amount
No dividends for ALMKT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
EPA:ALMKT (1/13/2026, 7:00:00 PM)
0.0808
+0 (+1.51%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners6.18%
Inst Owner ChangeN/A
Ins Owners0.36%
Ins Owner ChangeN/A
Market Cap14.14M
Revenue(TTM)7.66M
Net Income(TTM)-10.40M
Analysts86.67
Price Target0.51 (531.19%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-16.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-400%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-24.75%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 0.75 | ||
| P/S | 1.85 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.16
EYN/A
EPS(NY)0.11
Fwd EY133.85%
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.04
BVpS-0.17
TBVpS-0.18
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -82.18% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 31.67% | ||
| FCFM | N/A |
ROA(3y)-45.6%
ROA(5y)-50.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y39.93%
GM growth 5YN/A
F-Score3
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 12.33% | ||
| Cap/Sales | 3.08% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.23 | ||
| Quick Ratio | 0.12 | ||
| Altman-Z | -7.85 |
F-Score3
WACC6.69%
ROIC/WACCN/A
Cap/Depr(3y)16.65%
Cap/Depr(5y)36.4%
Cap/Sales(3y)2.78%
Cap/Sales(5y)7.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-114.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.27%
EPS Next Y50%
EPS Next 2Y74.64%
EPS Next 3Y23.86%
EPS Next 5YN/A
Revenue 1Y (TTM)-26.96%
Revenue growth 3Y-0.2%
Revenue growth 5Y0.6%
Sales Q2Q%-4.62%
Revenue Next Year0%
Revenue Next 2Y38.6%
Revenue Next 3Y26.82%
Revenue Next 5YN/A
EBIT growth 1Y-594.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year7.14%
EBIT Next 3Y27.11%
EBIT Next 5YN/A
FCF growth 1Y-3920%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2465%
OCF growth 3YN/A
OCF growth 5YN/A
MAUNA KEA TECHNOLOGIES / ALMKT.PA FAQ
What is the ChartMill fundamental rating of MAUNA KEA TECHNOLOGIES (ALMKT.PA) stock?
ChartMill assigns a fundamental rating of 2 / 10 to ALMKT.PA.
What is the valuation status of MAUNA KEA TECHNOLOGIES (ALMKT.PA) stock?
ChartMill assigns a valuation rating of 4 / 10 to MAUNA KEA TECHNOLOGIES (ALMKT.PA). This can be considered as Fairly Valued.
How profitable is MAUNA KEA TECHNOLOGIES (ALMKT.PA) stock?
MAUNA KEA TECHNOLOGIES (ALMKT.PA) has a profitability rating of 1 / 10.
What is the financial health of MAUNA KEA TECHNOLOGIES (ALMKT.PA) stock?
The financial health rating of MAUNA KEA TECHNOLOGIES (ALMKT.PA) is 0 / 10.